Post-transcriptional regulation of plasminogen activator inhibitor type-1 expression in human pleural mesothelial

Sreerama Shetty1, Thirunavukkarasu Velusamy, Rashmi S Shetty

  • 1Texas Lung Injury Institute, The University of Texas Health Science Center at Tyler, 75708, USA. sreerama.shetty@uthct.edu

Insights

A novel protein, 6-phospho-d-gluconate-NADP oxidoreductase, binds plasminogen activator inhibitor type-1 (PAI-1) mRNA, regulating its stability. This interaction influences PAI-1 expression in pleural cells, impacting inflammation and malignancy.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Plasminogen activator inhibitor type-1 (PAI-1) is a key regulator of fibrinolysis and extracellular matrix remodeling.
  • PAI-1 activity is crucial in processes like inflammation and cancer, particularly in pleural diseases.
  • Previous studies indicated TGF-beta influences PAI-1 protein levels, suggesting post-transcriptional regulation.

Purpose of the Study:

  • To identify and characterize the protein responsible for regulating plasminogen activator inhibitor type-1 (PAI-1) mRNA stability.
  • To elucidate the mechanism by which this protein interacts with PAI-1 mRNA.
  • To investigate the role of this regulatory pathway in mesothelial and mesothelioma cells.

Main Methods:

  • Incubation of human pleural mesothelial (Met5A) cells with TGF-beta, phorbol myristate acetate, and cycloheximide to study PAI-1 mRNA regulation.
  • Detection and characterization of a PAI-1 mRNA binding protein (PAI-1 mRNABp) in cytoplasmic extracts.
  • RNA-binding assays using specific PAI-1 mRNA sequences and competitive inhibition experiments.
  • Protein purification and identification using conventional and affinity chromatography, followed by mass spectrometry.

Main Results:

  • A ~60 kD cytoplasmic protein, PAI-1 mRNABp, was detected in mesothelial and mesothelioma cells.
  • PAI-1 mRNABp specifically binds to a 33-nucleotide sequence in the 3' untranslated region of PAI-1 mRNA, which accelerates mRNA decay.
  • Overexpression of the binding sequence reduced PAI-1 mRNA decay and increased PAI-1 expression; TGF-beta attenuated the mRNABp-mRNA interaction.
  • The PAI-1 mRNABp was identified as 6-phospho-d-gluconate-NADP oxidoreductase.

Conclusions:

  • 6-phospho-d-gluconate-NADP oxidoreductase directly regulates PAI-1 mRNA stability through interaction with its 3' UTR.
  • This novel regulatory pathway influences PAI-1 expression at the mRNA level in pleural cells.
  • The findings provide new insights into the control of PAI-1 in pleural inflammation and malignancy.